Introduction
The Halene Laboratory focuses on the study of myeloid malignancies and hematopoiesis. In particular we seek to understand the role of mutations in splicing factors, present in nearly 50% of patient with Myelodysplasia (MDS) and Acute Myeloid Leukemia (AML). In addition, we seek to establish a “co-clinical” model for MDS and AML with the goal to facilitate the translation of improved, less toxic, and more efficient treatments for MDS and AML into the clinic.
Twitter Feed
@Halene_lab Retweeted @Dr_AmerZeidanStephanie Halene @Halene_lab from @YaleHematology presenting great progress on #MDSsm animal models and their translational applications @YaleCancer @Rana_Gbyli @Dr_YuanbinSong #iwMDS #iwMDS22 https://t.co/At71yWB8pW6 DAYS AGO
@Halene_lab Retweeted @VJHemOncAt #iwMDS22 Stephanie Halene (@Halene_lab) takes us through MDS animal models
#iwMDS #MDS #MDSsm @Dr_AmerZeidan https://t.co/BH1dXDZ8Xo6 DAYS AGO
@Halene_lab Retweeted @YaleRNAWe are happy to announce our Single-cell RNA-seq workshop!
Next Tuesday June 21 with the talks of @RongFan8 @KrishnaswamyLab, Hongyu Zhao and Rui Chang Labs
Then join us in our end-of-year reception! All RNA Center members welcome
Details in the flyer 👇and in our website https://t.co/tohWdZrQU216 DAYS AGO
Principal Investigator
Stephanie Halene, MD, PhD
Associate Professor of Medicine (Hematology)
Contact Information
- Office
- Appt